Suppr超能文献

使用生物制剂治疗银屑病相关的潜在并发症。

Potential complications associated with the use of biologic agents for psoriasis.

作者信息

Zeichner Joshua A, Lebwohl Mark

机构信息

Department of Dermatology, Mount Sinai Medical Center, 5 East 98th Street, Box 1048, New York, NY 10029, USA.

出版信息

Dermatol Clin. 2007 Apr;25(2):207-13, vii. doi: 10.1016/j.det.2007.01.010.

Abstract

The biologic agents are effective drugs to treat psoriasis. They provide physicians with additional options for patients who cannot tolerate traditional therapies or for whom traditional therapies are not sufficient. While these new TNF-alpha inhibitors and anti-T-cell agents have potential complications, they are generally safe with proper monitoring. Both physicians and patients should be aware of the risks involved with each medicine so that the correct drug is chosen to suit each patient.

摘要

生物制剂是治疗银屑病的有效药物。它们为那些无法耐受传统疗法或传统疗法效果不佳的患者提供了更多选择。虽然这些新型肿瘤坏死因子-α抑制剂和抗T细胞药物存在潜在并发症,但在适当监测下总体是安全的。医生和患者都应了解每种药物所涉及的风险,以便选择适合每位患者的正确药物。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验